این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Middle East Journal of Digestive Diseases، جلد ۱، شماره ۱، صفحات ۳۴-۴۳
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Risk Factors Affecting 90-day Readmission of Patients with Inflammatory Bowel Disease
چکیده انگلیسی مقاله BACKGROUNDS: Hospital readmission rate is considered as a quality and accountability measure, understanding the corresponding modifiable risk factors of which may moderate cost burden imposed on patients with inflammatory bowel disease (IBD) and health system. METHODS: Retrospective analysis was performed on the data extracted from hospital records during a 4-year period. The study setting encompassed three referral hospitals in Tehran and the south of Iran. The primary outcome was hospital readmission of patients with IBD. The factors associated with binary and categorical dependent variables were analyzed using robust logistic regression and multinomial logistic regression, respectively. The significance level was set at p= 0.05. RESULTS: 187 patients were admitted during the 4-year study period for an IBD-related reason, among whom 131 patients (70.1%) had ulcerative colitis (UC), and 56 patients (29.9%) had Crohn’s disease (CD). Moreover, 29% (55) of the participants had been readmitted at least once during the study period, and seven patients with IBD had been readmitted five or more times during the study period. Corticosteroids (OR=4.55, 95% confidence interval CI: 1.65- 12.55) and chronic pain (OR=6.65, 95% CI: 1.73-25.62) were two factors associated with their readmission within 90 days. For the patients with five or more times of readmissions, Corticosteroids (RRR=5.68), chronic pain (RRR=5.05), length of hospital stay (RRR=0.69), and age (RRR=0.9) could significantly explain the hospital readmissions. CONCLUSION: About one in seven hospitalizations of patients with IBD leads to 30-day readmission. Moreover, younger patients with IBD and shorter length of hospital stay were more likely to be readmitted five or more times during the study period. The use of corticosteroids and the presence of chronic pain were predictors of 90-day readmission. More studies are needed to detect the best management plan for chronic pains.
کلیدواژه‌های انگلیسی مقاله Inflammatory Bowel Disease,,COVID-19,,Pandemic,,Concern,,Cohort Study
نویسندگان مقاله | Sulmaz Ghahramani
Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.


| Zahra Tamartash
Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.


| Mohammad Sayari
Health Policy Research Center, Institute of Health, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.


| Homayoun Vahedi
Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.


| Fatemeh Karimiyan
Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.


| Sadegh Heydari
Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.


| Kamran Bagheri Lankarani


نشانی اینترنتی http://mejdd.org/index.php/mejdd/article/view/2474
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات